Company Overview of Zacharon Pharmaceuticals, Inc.
Zacharon Pharmaceuticals, Inc. engages in the research and development of molecules targeting pathways of glycan and glycolipid metabolism. It offers ZP103, which is an anti-metastatic glycan inhibitor. The company has a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. Zacharon Pharmaceuticals, Inc. was incorporated in 2001 and is based in San Diego, California. As of January 4, 2013, Zacharon Pharmaceuticals, Inc. operates as a subsidiary of BioMarin Pharmaceutical Inc.
5626 Oberlin Drive
San Diego, CA 92121
Founded in 2001
Key Executives for Zacharon Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Neon Therapeutics Inc.||United States|
|Targetech Inc.||United States|
|Syngenta Biotechnology, Inc.||United States|
|Viragen International, Inc.||United States|
|Phylos, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Zacharon Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.